Mesabi Trust (MSB) News
Track canonical SquawkNews coverage tagged to MSB, Mesabi Trust. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
MSB expects double-digit growth on $115M FY26 revenue
MSB projects $115M FY26 revenue, citing strong pipeline progress and expected double-digit growth next year.
EARNINGS | Aug 26, 2026, 11:54 PM UTC
M
MSB revenue jumps; net loss halves; clinical milestones met
MSB reports revenue up 600% to $120M and net loss halved, alongside key clinical milestones achieved.
EQUITY | Aug 26, 2026, 11:05 PM UTC
L
MSB: RYONCIL's $115M launch year revenue fuels late-stage pipeline and strengthens financial position
MSB: RYONCIL's $115M launch year revenue fuels late-stage pipeline and strengthens financial position
EQUITY | Aug 26, 2026, 11:01 PM UTC
M
MSB reports 599% revenue surge on Ryoncil US launch
MSB says revenues rose 599% to $120.3M with Ryoncil®’s US launch. Net loss fell 44% to $57.5M.
EQUITY | Aug 26, 2026, 10:35 PM UTC